Salt / ingredient
Empagliflozin 10mg
Controls sugar, protects heart/kidney
MRP data last verified: August 2026. Source: NPPA Pharma Sahi Daam, reproduced under the NPPA copyright policy.
Private-brand substitutes: kam se zyada
More about this medicine
Reference information
About Empagliflozin
This information is from US FDA labels, for reference only. Always follow your doctor's advice.
Common side effects
- associated with empagliflozin (5% or greater incidence) were urinary tract infections
- female genital mycotic infections
Safety advice
- May affect the liver. Tell your doctor if you have liver problems.
- May affect the kidneys. Tell your doctor if you have kidney problems.
- Avoid or limit alcohol while taking this medicine.
- Stop use and seek emergency help if you have signs of a severe allergic reaction.
- May cause low blood sugar. Watch for symptoms like shakiness, sweating, confusion.
Uses
- is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin hydrochloride (HCl) immediate-release, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.
- XR XR is a combination of empagliflozin, a SGLT2 inhibitor and metformin HCl extended-release, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus .
- Empagliflozin Empagliflozin, when used as a component of or XR, is indicated in adults with type 2 diabetes mellitus to reduce the risk of: Cardiovascular (CV) death in adults with established CV disease.
- ( 1 ) CV death and hospitalization for heart failure in adults with heart failure.
- ( 1 ) Sustained decline in eGFR, end-stage kidney disease, CV death, and hospitalization in adults with chronic kidney disease at risk of progression.
How to take
- ssess renal function before initiating and as clinically indicated.
- Assess volume status and correct volume depletion before initiating.
- ( 2.1 ) Individualize the starting dosage based on the patient's current regimen and renal function.
- ( 2.2 , 2.3 , 2.4 ) The maximum recommended dosage is 25 mg/day of empagliflozin and 2,000 mg/day of metformin HCl.
- ( 2.2 , 2.3 ) Initiation of or XR is not recommended in patients with an eGFR less than 45 mL/min/1.73 m 2 , due to the metformin HCl component.
Frequently Asked Questions about Empagliflozin 10mg
What is the price of Empagliflozin 10mg in India?
The price of Empagliflozin 10mg in India depends on the manufacturer and channel. Official Government Jan Aushadhi generic rates start at ₹3.75 per unit.Private commercial brands vary from low-cost options to higher-priced branded formulations.
Is a Government Jan Aushadhi generic available for Empagliflozin 10mg?
Empagliflozin 10mg is listed under PMBI Jan Aushadhi (PMBI Code 1609) at ₹37.50 per pack.
How to find lower-cost substitutes for Empagliflozin 10mg?
Search the active salt formulation (Empagliflozin 10mg) on Sasta Parcha to view private-brand substitutes ranked strictly low-to-high by per-unit price. Always consult your prescribing doctor or pharmacist before changing medicine brands.